No Data
No Data
Avita Medical Price Target Cut 9% to A$2.75/Share by Wilsons
Avita Medical Price Target Cut 9% to A$2.75/Share by Wilsons
AVITA Downgraded by Piper Sandler Over Sales Outlook
Piper Sandler: The AVITA Medical (RCEL.US) rating was lowered from an increase in holdings to a neutral rating, and the target price was adjusted from $21.00 to $9.00.
Piper Sandler: The AVITA Medical (RCEL.US) rating was lowered from an increase in holdings to a neutral rating, and the target price was adjusted from $21.00 to $9.00.
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Inotiv (NOTV) and Hims & Hers Health (HIMS)
Bank of America Securities Remains a Buy on Avita Medical (RCEL)
Avita Medical Is Maintained at Overweight by Cantor Fitzgerald
Avita Medical Is Maintained at Overweight by Cantor Fitzgerald
No Data